Univ.- Prof. Dr. med. Marion Subklewe
Univ.- Prof. Dr. med. Marion Subklewe
LMU - Klinikum der Universität München, Med. Klinik III
Verified email at - Homepage
Cited by
Cited by
Cytokine release syndrome
A Shimabukuro-Vornhagen, P Gödel, M Subklewe, HJ Stemmler, ...
Journal for immunotherapy of cancer 6, 1-14, 2018
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
K Inaba, S Turley, F Yamaide, T Iyoda, K Mahnke, M Inaba, M Pack, ...
The Journal of experimental medicine 188 (11), 2163-2173, 1998
Structures of the human and Drosophila 80S ribosome
AM Anger, JP Armache, O Berninghausen, M Habeck, M Subklewe, ...
Nature 497 (7447), 80-85, 2013
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
KH Metzeler, T Herold, M Rothenberg-Thurley, S Amler, MC Sauerland, ...
Blood, The Journal of the American Society of Hematology 128 (5), 686-698, 2016
Advances in cancer immunotherapy 2019–latest trends
S Kruger, M Ilmer, S Kobold, BL Cadilha, S Endres, S Ormanns, ...
Journal of Experimental & Clinical Cancer Research 38, 1-11, 2019
The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3
MM Gaidt, TS Ebert, D Chauhan, K Ramshorn, F Pinci, S Zuber, F O’Duill, ...
Cell 171 (5), 1110-1124. e18, 2017
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion
J Engelmayer, M Larsson, M Subklewe, A Chahroudi, WI Cox, ...
The Journal of Immunology 163 (12), 6762-6768, 1999
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ...
The Lancet 398 (10299), 491-502, 2021
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
C Münz, KL Bickham, M Subklewe, ML Tsang, A Chahroudi, MG Kurilla, ...
The Journal of experimental medicine 191 (10), 1649-1660, 2000
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021
A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
A Reddy, M Sapp, M Feldman, M Subklewe, N Bhardwaj
Blood, The Journal of the American Society of Hematology 90 (9), 3640-3646, 1997
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
S Haubner, F Perna, T Köhnke, C Schmidt, S Berman, C Augsberger, ...
Leukemia 33 (1), 64-74, 2019
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
C Krupka, P Kufer, R Kischel, G Zugmaier, FS Lichtenegger, T Köhnke, ...
Leukemia 30 (2), 484-491, 2016
CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma
K Rejeski, A Perez, P Sesques, E Hoster, C Berger, L Jentzsch, ...
Blood, The Journal of the American Society of Hematology 138 (24), 2499-2513, 2021
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330
C Krupka, P Kufer, R Kischel, G Zugmaier, J Bögeholz, T Köhnke, ...
Blood, The Journal of the American Society of Hematology 123 (3), 356-365, 2014
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the …
PJ Hayden, C Roddie, P Bader, GW Basak, H Bonig, C Bonini, ...
Annals of Oncology 33 (3), 259-275, 2022
Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP …
RU Trappe, D Dierickx, H Zimmermann, F Morschhauser, P Mollee, ...
Journal of Clinical Oncology 35 (5), 536-543, 2017
Features of human CD3+ CD20+ T cells
E Schuh, K Berer, M Mulazzani, K Feil, I Meinl, H Lahm, M Krane, ...
The Journal of Immunology 197 (4), 1111-1117, 2016
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
T Herold, M Rothenberg-Thurley, VV Grunwald, H Janke, D Goerlich, ...
Leukemia 34 (12), 3161-3172, 2020
Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells
FS Lichtenegger, M Rothe, FM Schnorfeil, K Deiser, C Krupka, ...
Frontiers in immunology 9, 385, 2018
The system can't perform the operation now. Try again later.
Articles 1–20